What are the recommended contraception methods for postpartum (puerperal) women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Postpartum Contraception Recommendations

Immediate Postpartum Options (All Women)

Progestin-only methods and IUDs can be initiated immediately after delivery and are the preferred first-line options for postpartum contraception, while combined hormonal contraceptives must be delayed based on breastfeeding status and VTE risk. 1, 2

Long-Acting Reversible Contraception (LARC) - Highest Efficacy

  • Etonogestrel implant (Nexplanon) can be inserted immediately postpartum, including before hospital discharge, with no restrictions (U.S. MEC Category 1 for non-breastfeeding women; Category 2 if <21 days postpartum for breastfeeding women). 1, 2

    • Requires 7 days of backup contraception if inserted ≥21 days postpartum when menses has not returned. 2
    • Failure rate <0.05% with typical use. 1
  • Levonorgestrel IUD (Mirena) can be inserted immediately postpartum (Category 1 if inserted <10 minutes after placental delivery; Category 2 if inserted later in first 21 days). 1, 2

    • After 30 days postpartum, becomes Category 1 for all women. 1
    • Failure rate 0.2% with typical use. 1
  • Copper IUD (Paragard) follows same timing guidelines as levonorgestrel IUD and provides 10 years of protection. 1

    • Can also serve as emergency contraception if inserted within 5 days of unprotected intercourse. 1
    • Failure rate 0.8% with typical use. 1

Progestin-Only Pills

  • Can be started immediately postpartum in both breastfeeding and non-breastfeeding women (U.S. MEC Category 1 for non-breastfeeding; Category 2 if <21 days for breastfeeding). 1, 2
  • Require only 2 days of backup contraception if started ≥21 days postpartum when menses has not returned. 2, 3
  • Do not affect milk volume or composition. 3, 4

Depot Medroxyprogesterone Acetate (DMPA/Depo-Provera)

  • Can be initiated immediately postpartum (U.S. MEC Category 1 for non-breastfeeding; Category 2 if <21 days for breastfeeding). 1
  • Failure rate 6% with typical use. 1

Combined Hormonal Contraceptives - Timing Algorithm

Non-Breastfeeding Women

Combined hormonal contraceptives (pills, patch, ring) are absolutely contraindicated for the first 21 days postpartum due to elevated VTE risk (U.S. MEC Category 4). 1, 2

  • Days 0-20: Contraindicated (Category 4) - unacceptable health risk. 1, 2

  • Days 21-29:

    • Without VTE risk factors: Can initiate (Category 2) - advantages generally outweigh risks. 1, 2
    • With VTE risk factors: Generally should not use (Category 3) - risks usually outweigh advantages. 1, 2
  • Days 30-42:

    • Without VTE risk factors: Can initiate (Category 2). 1
    • With VTE risk factors: Generally should not use (Category 3). 1, 2
  • After 42 days: No restrictions (Category 1) for otherwise healthy women. 1, 5

Common VTE risk factors include: age ≥35 years, previous VTE, thrombophilia, immobility, transfusion at delivery, BMI ≥30 kg/m², postpartum hemorrhage, post-cesarean delivery, preeclampsia, or smoking. 1

Breastfeeding Women

Breastfeeding women should avoid combined hormonal contraceptives until at least 6 weeks postpartum, preferably waiting until after 6 months. 2, 3, 6

  • Days 0-20: Contraindicated (Category 4) due to VTE risk. 2, 6

  • Days 21-29: Generally should not use (Category 3) due to potential negative effects on breastfeeding performance and milk production. 1, 2, 6

  • Days 30-42:

    • Without VTE risk factors: Generally should not use (Category 3) due to lactation concerns. 1, 2
    • With VTE risk factors: Generally should not use (Category 3). 1, 2
  • After 42 days to 6 months: Advantages generally outweigh risks (Category 2), but progestin-only methods remain preferred. 2, 6

  • After 6 months: Combined hormonal contraceptives become fully appropriate (Category 2) as concerns about milk production and infant hormone exposure are resolved. 6

Backup Contraception Requirements

When Starting Combined Hormonal Contraceptives

  • Use backup contraception or abstain for 7 days if starting when menses has not returned or if >5 days since menstrual bleeding started. 1, 2, 3
  • No backup needed if starting within 5 days of menstrual bleeding onset. 2

When Starting Progestin-Only Methods

  • Progestin-only pills: 2 days of backup if started ≥21 days postpartum when menses has not returned. 2, 3
  • Etonogestrel implant: 7 days of backup if inserted ≥21 days postpartum when menses has not returned. 2
  • IUDs and DMPA: No backup contraception needed. 1

Critical Clinical Pitfalls to Avoid

Waiting until the 6-week postpartum visit to initiate contraception in low-risk, non-breastfeeding women is a common error. 2

  • Combined hormonal contraceptives can safely be started at 3 weeks (21 days) in non-breastfeeding women without VTE risk factors. 2
  • Progestin-only methods and IUDs can be initiated immediately, removing barriers to care and preventing unintended pregnancy during the early postpartum period. 1, 2
  • Immediate postpartum insertion of implants or IUDs (before hospital discharge) is safe, effective, and strongly supported by ACOG and CDC. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Postpartum Combined Oral Contraceptive Initiation Timing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Contraception for Breastfeeding Women with Return of Menses

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Combined Oral Contraceptive Pills After 6 Months of Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.